ArticleBMC genomic data2025
Draft genome sequence of Exiguobacterium acetylicum GM-14 isolated from beans.
Article in BMC genomic data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Draft genome sequence of Exiguobacterium acetylicum GM-14 isolated from beans.BMC genomic data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe bacterial genus Exiguobacterium includes many versatile species isolated from diverse environments. This draft genome can serve as a fundamental tool for subsequent studies, including the design of specific primers for strain identification, and as a basis for comparative genomics. DATA DESCRIPTION: Herein, we report the draft genome sequence of Exiguobacterium acetylicum GM-14, which was isolated from a conventionally grown bean (Phaseolus vulgaris) field located in Culiacán, Sinaloa, Mexico. The nucleotide sequence of this genome was deposited into NCBI GenBank under accession number PRJNA 1,175,395. In this report, we introduce the entire genomic sequence of Exiguobacterium acetylicum GM-14, which is 3,139,301 bp long, with a 47.3% G + C content and 3,178 coding sequences (CDSs). The use of the Exiguobacterium acetylicum GM-14 genome to help analyse possible virulence genes will contribute to the development of control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.